Company Filing History:
Years Active: 2020-2025
Title: The Innovations of Jeffrey J Tabor
Introduction
Jeffrey J Tabor is a prominent inventor based in Houston, TX (US). He has made significant contributions to the field of biotechnology, particularly in the development of expression systems and signal transduction methods. With a total of 2 patents, Tabor's work has the potential to advance scientific research and applications in various domains.
Latest Patents
Tabor's latest patents include an inducible promoter expression system based on the T7 RNA Polymerase (T7 RNAP), lactose repressor (Lad), and a chimeric T7lac promoter (PT7lac). This innovative system can be integrated as a single copy into the genome. In the absence of IPTG, Lad strongly represses T7RNAP and PT7lac, making the expression of an exemplary ORF, such as the superfolder green fluorescent protein (sfGFP) reporter protein, undetectable by flow cytometry. The addition of IPTG de-represses PT7lac and simultaneously induces the expression of T7RNAP, resulting in very high levels of sfGFP. Another notable patent involves methods to create two-component signal transduction systems by replacing the DNA binding domains and output promoters in bacteria.
Career Highlights
Tabor is affiliated with William Marsh Rice University, where he continues to push the boundaries of research and innovation. His work has garnered attention for its practical applications in biotechnology and molecular biology.
Collaborations
Tabor collaborates with esteemed colleagues such as Sebastian Schmidl and Ravi Sheth, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Jeffrey J Tabor's contributions to biotechnology through his patents and research at William Marsh Rice University highlight his role as a leading inventor in the field. His innovative approaches to expression systems and signal transduction are paving the way for future advancements in scientific research.